Construction and immunogenicity study of a newly construct DNA vaccine candidate against tuberculosis in mice

Asia-Pacific Journal of Molecular Biology and Biotechnology

Volumn 17, Issue 1, 2009, Pages 3-9

  Fauzi, Agustine Nengsih ^a   Musa, Mustaffa ^a   Zainuddin, Zainul Fadziruddin ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Assembly PCR; DNA vaccine; M. tuberculosis

Indexed keywords

MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 65349102999     PISSN: 01287451     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Colditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E. & Fineberg, H. V. 1995. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta analyses of the published literature. Pediatrics 96: 29-35.
2. Colditz, G. A., Brewer, T. F., C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg & Mosteller., F. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analyses of the published literature. JAMA: 271:698-702.
3. Coler, R. N., Campos-Neto, A., Ovendale, P., Day, F. H., Fling, S. P., Zhu, L., Serbina, N., Flynn, J. L., Reed, S. G. & Alderson, M. R. 2001. Vaccination with the T cell antigen Mtb8.4 protects against challenge with Mycobacterium tuberculosis. Journal of Immununology 166: 6227-6235.
4. Coler, R. N., Skeiky, Y. A., Vedvick, T., Bement, T., Ovendale, P., Campos-Neto, A., Alderson, M. R. & Reed, S. G. 1998. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. Journal of Immununology 161: 2356-64.
5. Daoyin, Z., Shan, J. & Xudong, L. 2005. Therapeutic effects of Ag85B and MPT64 DNA vaccine in a murine model of Mycobacterium tuberculosis. Vaccine 23: 4619-4624.
6. Dye, C., Scheele, S., Dolin, P., Pathania, V. & Raviglione, M. C. 1999. Global burden of tuberculosis:estimated incidence, prevalence and mortality by country. WHO Global Surveillance Monitoring Project. Journal of American Medical Association 282: 677-686.
7. Flynn, J. L. 2004. Immunology of tuberculosis and its implications in vaccine development. Tuberculosis 84: 93-101.
8. Huygen, K. 2003. On the use of DNA vaccines for the prophylaxisof mycobacterial diseases. Infection and Immunity 71: 1613-21.
9. Huygen, K., Content, J. & Denis, O. 1996. Immunogenecity and protective efficacy of a tuberculosis DNA vaccine. Nature Medicine 2: 893-8.
10. Jacobs, R.F. 1994. Multiple-drug-resistant tuberculosis. Clinical Infectious Diseases 19: 1-10
11. Kamath, A. T., Feng, C. G., Macdonald, M., Briscoe, H. & Britton, W. J. 1999. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infection and Immunity 67: 1702-7.
12. Kozak, M. 1986. An analysis of 5'-noncoding sequences from 699 vebtebrate messenger RNAs. Nucleic Acid Research 15: 8125-48.
13. Kumar, H., Malhotra, D., Goswami, S. & Bamezail, R. N. K. 2003. How far have we reached in Tuberculosis vaccine development? Critical Review in Microbiology 29: 297-312.
14. Launois, P, Deleys, R, Niang, M.N, Drowart, A, Andrien, M, Huygen, K. 1994. T-cell epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infection and Immunity 62: 3679-3687.
15. Lauzardo, M. & Ashkin, D. 2000. Phthisiology at the dawn of a new century. American College of Chest Physician 117: 1455-73.
16. Lee, B. Y. & Marcus, A. H. 1999. T-cell epitopes mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. Infection and Immunity 67: 2665-2670.
17. Lowrie, D. B., Tasco, R. E. & Bonato, V. L. D. 1999. Theraphy of tuberculosis in mice by DNA vaccination. Nature 400: 269-71.
18. Mauricio, C.-A., Yolanda, L.-V., Clara, E.-P. & Rogelio, H. 2005. A new vaccine against tuberculosis show the greater protection in a mouse model with progressive pulmonary tuberculosis. Tuberculosis 85: 115-126.
19. Norazmi, N.M, Mustaffa, M. 2004. Approaches towards the development of vaccine against Tuberculosis : recombinant BCG and DNA vaccine. Tuberculosis 84: 102-109.
20. Sambrook, J. & Rusell, D. W. 2001. Molecular cloning: a laboratory manual, Cold Spring Harbour Laboratory Press, N Y.
21. Silva, C. L., Bonato, V. L. D., Lima, K. M., Coelho-Castelo, A. A. M., Faccioli, L. H., Sartori, A., De Sauza, A. O. & Leao, S. C. 2001. Cytotoxic T cells and mycobacteria. FEMS Microbiology Letters 197: 11-18.
22. Stemmer, W. P. C., Crameri, A., Ha, K. D., Brennan, T. M. & Heynecker, H. L. 1995. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164: 49-53.
23. Sterne, J.A, Rodrigues, L.C, Guedes, I.N. 1998. Does the efficacy of BCG decline with time since vaccination? International Journal of Tuberculosis and Lung Disease 2: 200-207
24. Ulmer, J. B., Wahren, B. & Liu, M. A. 2006. Gene-based vaccines: recent technical and clinical advances. Trends in Molecular Medicine 12: 216-222.
25. Wiker, H. G. & Harboe, M. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiological Reviews 56: 648-661.